Application of exogenous products, such as creams, to the skin can result in subclinical changes in selected epidermal functions such as transepidermal water loss (TEWL), hydration, redness, and pH; these changes may lead to or contribute to irritation. Changes in skin surface inflammatory factors may provide further insight into this potential for irritation. The objective of this study was to evaluate the changes in epidermal properties and inflammatory mediators after 4 days of topical application of 2 different polymers formulated in cosmetic creams. Ten healthy volunteers (mean age ± SD: 20.0 ± 2.4 years) completed the study. TEWL, color, and pH were not significantly different after repeated application of these polymers. Hydration was significantly lower at sites treated with polymer A after 5 days. Significant increases in IL-1α, IL-1RA, and IL-1β were observed after cream application at sites treated with polymer A. This is the first study to apply noninvasive measurements to quantify subclinical changes in epidermal properties and inflammatory mediator expression before and after the application of a cosmetic product, which will allow for a more enhanced safety profile to be achieved.

Keywords:
Epidermis, Inflammation, Irritation, Cosmetic, Topical application, Transepidermal water loss, Hydration, Cytokine, Chemokine
1.
Buraczewska I, Berne B, Lindberg M, Torma H, Loden M: Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156: 492–498.
2.
Loden M: The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol 2005; 19: 672–688; quiz 686–677.
3.
Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90: 482–487.
4.
Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR: Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 1996; 106: 397–403.
5.
Wang XP, Schunck M, Kallen KJ, Neumann C, Trautwein C, Rose-John S, Proksch E: The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 2004; 123: 124–131.
6.
Nickoloff BJ, Naidu Y: Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994; 30: 535–546.
7.
Sidgwick GP, McGeorge D, Bayat A: Functional testing of topical skin formulations using an optimised ex vivo skin organ culture model. Arch Dermatol Res 2016; 308: 297–308.
8.
Kinn PM, Holdren GO, Westermeyer BA, Abuissa M, Fischer CL, Fairley JA, Brogden KA, Brogden NK: Age-dependent variation in cytokines, chemokines, and biologic analytes rinsed from the surface of healthy human skin. Sci Rep 2015; 5: 10472.
9.
Akaike H: A new look at the statistical model identification. IEEE Trans Autom Control 1974; 19: 716–723.
10.
Kompaore F, Marty JP, Dupont C: In vivo evaluation of the stratum corneum barrier function in blacks, Caucasians and Asians with two noninvasive methods. Skin Pharmacol 1993; 6: 200–207.
11.
Grimes P, Edison BL, Green BA, Wildnauer RH: Evaluation of inherent differences between African American and white skin surface properties using subjective and objective measures. Cutis 2004; 73: 392–396.
12.
Boer M, Duchnik E, Maleszka R, Marchlewicz M: Structural and biophysical characteristics of human skin in maintaining proper epidermal barrier function. Postepy Dermatol Alergol 2016; 33: 1–5.
13.
De Jongh CM, Lutter R, Verberk MM, Kezic S: Differential cytokine expression in skin after single and repeated irritation by sodium lauryl sulphate. Exp Dermatol 2007; 16: 1032–1040.
14.
Treffel P, Panisset F, Faivre B, Agache P: Hydration, transepidermal water loss, pH and skin surface parameters: correlations and variations between dominant and non-dominant forearms. Br J Dermatol 1994; 130: 325–328.
15.
Black DA, Del Pozo A, Lagarde JM, Gall Y: Seasonal variability in the biophysical properties of stratum corneum from different anatomical sites. Skin Res Technol 2000; 6: 70–76.
16.
Cravello B, Ferri A: Relationships between skin properties and environmental parameters. Skin Res Technol 2008; 14: 180–186.
17.
Schnetz E, Diepgen TL, Elsner P, Frosch PJ, Klotz AJ, Kresken J, Kuss O, Merk H, Schwanitz HJ, Wigger-Alberti W, Fartasch M: Multicentre study for the development of an in vivo model to evaluate the influence of topical formulations on irritation. Contact Dermatitis 2000; 42: 336–343.
18.
Bornkessel A, Flach M, Arens-Corell M, Elsner P, Fluhr JW: Functional assessment of a washing emulsion for sensitive skin: mild impairment of stratum corneum hydration, pH, barrier function, lipid content, integrity and cohesion in a controlled washing test. Skin Res Technol 2005; 11: 53–60.
19.
Berardesca E, Pirot F, Singh M, Maibach H: Differences in stratum corneum pH gradient when comparing white Caucasian and black African-American skin. Br J Dermatol 1998; 139: 855–857.
20.
Sehra S, Yao Y, Howell MD, Nguyen ET, Kansas GS, Leung DY, Travers JB, Kaplan MH: IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol 2010; 184: 3186–3190.
21.
Perkins MA, Osterhues MA, Farage MA, Robinson MK: A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation. Skin Res Technol 2001; 7: 227–237.
22.
Angelova-Fischer I, Becker V, Fischer TW, Zillikens D, Wigger-Alberti W, Kezic S: Tandem repeated irritation in aged skin induces distinct barrier perturbation and cytokine profile in vivo. Br J Dermatol 2012; 167: 787–793.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.